The global oncology targeted therapy market, valued at $93.86B in 2025, is poised for steady growth fueled by rising cancer prevalence, technological advancements, and increased R&D. Discover key trends, leading companies (Bayer, Eisai, Novartis), and regional market insights in this comprehensive analysis. Explore Sorafenib, Lenvatinib, and other leading therapies.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.